Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
N/A
A pilot study to evaluate the feasibility of a NGS-based tumour BRCA1/2 mut...
Status
Completed
Location
Mater Misericordiae University Hospital / Mater Private Hospital
Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
PHASE2
This phase II trial studies whether adding pembrolizumab to olaparib (stand...